Lexaria Bioscience (LEXX) Free Cash Flow (2010 - 2026)
Lexaria Bioscience (LEXX) posted Free Cash Flow of -$1.64 million for fiscal Q3 2026 (quarter ended May 31, 2026), compared with -$3.58 million a year earlier.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Free Cash Flow (2010 - 2026) Analysis & Trends
For the trailing twelve months through May 31, 2026, Free Cash Flow at Lexaria Bioscience was -$7.47 million; for FY2025 (ended Aug 31, 2025), it was -$10.48 million.
- In prior fiscal years, Lexaria Bioscience's Free Cash Flow was -$5 million in FY2024, -$5.91 million in FY2023, -$4.93 million in FY2022 and -$3.99 million in FY2021.
- Quarterly Free Cash Flow has run from a low of -$3.58 million in fiscal Q3 2025 to a high of -$619,614 in fiscal Q2 2024 over five years.
- According to Business Quant data, Free Cash Flow for the three prior fiscal quarters was -$2.2 million (Q2 2026), -$984,098 (Q1 2026) and -$2.64 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 6.20 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 5.34 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.43 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 302.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.01 Bn |
| 10 | Lexaria Bioscience | 3.26 Mn | -12.39 Mn | - | -1.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -1.64 Mn |
| Feb 28, 2026 | -2.20 Mn |
| Nov 30, 2025 | -984,098.00 |
| Aug 31, 2025 | -2.64 Mn |
| May 31, 2025 | -3.58 Mn |
| Feb 28, 2025 | -1.50 Mn |
| Nov 30, 2024 | -2.75 Mn |
| Aug 31, 2024 | -1.93 Mn |
| May 31, 2024 | -1.27 Mn |
| Feb 29, 2024 | -619,614.00 |
| Nov 30, 2023 | -1.18 Mn |
| Aug 31, 2023 | -1.62 Mn |
| May 31, 2023 | -1.79 Mn |
| Feb 28, 2023 | -1.24 Mn |
| Nov 30, 2022 | -1.27 Mn |
| Aug 31, 2022 | -1.18 Mn |
| May 31, 2022 | -1.27 Mn |
| Feb 28, 2022 | -1.28 Mn |
| Nov 30, 2021 | -1.21 Mn |
| Aug 31, 2021 | -1.11 Mn |
API Access
Lexaria Bioscience Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();